mjzanon - Brazil IP counsel for foreign law firms, agents and in-house teams. - Page 158

First international standard on #AI collaboration and security expected by 2020

The world’s first international standard on AI collaboration and security is expected to be published by 2020, which will further

Regeneron and Sanofi strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies

Monday, February 25, 2019 DrugName : alirocumab Regeneron Pharmaceuticals, Inc., and Sanofi announced they strongly disagree with certain aspects

Aurinia receives notice of allowance from the US Patent and Trademark Office for claims directed to its novel voclosporin dosing protocol for lupus nephritis

Monday, February 25, 2019 | Sentiment: Positive | DrugName : voclosporin Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company

FDA issues 74 product-specific guidances to help promote generic drug access and drug competition

Friday, February 22, 2019 The U.S. Food and Drug Administration announced a new set of product-specific guidances to support industry

Optinose announces issuance of four additional U.S. patents covering XHANCE

Tuesday, February 19, 2019 Precautionary measures: Utilization of Sildenafil Citrate is not a generic version of rx tadalafil. The impact

Brazil IP counsel for foreign law firms, agents and in-house teams.